
Context Therapeutics and Integral Molecular have announced a research collaboration and licensing agreement for the development of an anti-claudin 6 …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

